| Financial Year |
March 31 2023 |
| Monetary Funds |
1,056,078,979.23 |
| Held-for-trading Financial Assets |
9,999,000.00 |
| Notes Receivable |
700,000.00 |
| Accounts Receivable |
62,132,204.46 |
| Advances to Suppliers |
31,908,313.78 |
| Other Receivables |
5,702,795.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
591,697,100.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,898,688.11 |
| Total Current Assets |
1,779,117,081.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
257,975,173.14 |
| Investment Properties |
-- |
| Fixed Assetes |
1,551,143,396.78 |
| Under-construction Projects |
210,667,855.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
879,840.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,307,732.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,199,430.98 |
| Deferred Income Tax Assets |
33,564.45 |
| Other Non-Current Assets |
145,105,283.49 |
| Sub-Total of Non-Current Assets |
2,357,652,960.49 |
| Total Assets |
4,136,770,042.26 |
| Short-Term Loans |
1,082,230,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,000,000.00 |
| Accounts Payable |
111,202,027.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,255,051.63 |
| Taxes Payable |
4,363,738.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,546,060.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,849,653.43 |
| Other Current Liabilities |
591,938.93 |
| Sub-Total of Current Liabilities |
1,297,308,801.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
115,610,071.64 |
| Total Liabilities |
1,412,918,873.33 |
| Paid-In Capital(Or Share Stock) |
348,960,212.00 |
| Capital Surplus |
1,381,794,233.05 |
| Surplus Reserve |
260,596,530.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
739,171,984.54 |
| Minority Stockholder's Interest |
-6,728,327.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,730,579,496.36 |
| Owner's Equity（Stockholder's Equity） |
2,723,851,168.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,136,770,042.26 |
